Liese Barbier

Leuven, VLG, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

Editorial: Regulatory science: addressing uncertainties in medicines development, evaluation and use.

Editorial: Regulatory science: addressing uncertainties in medicines development, evaluation and use.

Journal: Frontiers in medicine

Published: March 20, 2026

Toward Regulatory Convergence and Streamlined Biosimilar Development: Recommendations from an International Qualitative Study.

Toward Regulatory Convergence and Streamlined Biosimilar Development: Recommendations from an International Qualitative Study.

Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

Published: September 21, 2025

A Fast Path from Innovation to Safe and Effective Medicines.

A Fast Path from Innovation to Safe and Effective Medicines.

Journal: Clinical pharmacology and therapeutics

Published: July 01, 2025

Evolving global regulatory landscape for approval of biosimilars: current challenges and opportunities for convergence.

Evolving global regulatory landscape for approval of biosimilars: current challenges and opportunities for convergence.

Journal: Expert opinion on biological therapy

Published: May 26, 2025

Future-Proofing European Pharmaceutical Regulatory and Market Access Practices Based on EU Learnings from the COVID-19 Pandemic: Insights from Multi-Stakeholder Interviews.

Future-Proofing European Pharmaceutical Regulatory and Market Access Practices Based on EU Learnings from the COVID-19 Pandemic: Insights from Multi-Stakeholder Interviews.

Journal: Therapeutic innovation & regulatory science

Published: April 04, 2025

Compulsory Licensing as an Instrument to Tackle High Medicine Prices: A Realist Review of Industrial and Health Consequences.

Compulsory Licensing as an Instrument to Tackle High Medicine Prices: A Realist Review of Industrial and Health Consequences.

Journal: Applied health economics and health policy

Published: February 19, 2025

A new European platform for advancing regulatory science research.

A new European platform for advancing regulatory science research.

Journal: Nature reviews. Drug discovery

Published: February 10, 2025

Do European regulatory measures accelerate national market access in Belgium? A retrospective analysis of medicines centrally authorised between 2015 and 2020.

Do European regulatory measures accelerate national market access in Belgium? A retrospective analysis of medicines centrally authorised between 2015 and 2020.

Journal: BMJ open

Published: January 09, 2025

Unmet medical needs definition and incentives: stakeholders perspectives on the reform of the EU pharmaceutical legislation.

Unmet medical needs definition and incentives: stakeholders perspectives on the reform of the EU pharmaceutical legislation.

Journal: Frontiers in medicine

Published: October 08, 2024

Mitigating the Nocebo Effect in Biosimilar Use and Switching: A Systematic Review.

Mitigating the Nocebo Effect in Biosimilar Use and Switching: A Systematic Review.

Journal: Pharmaceutical medicine

Published: September 26, 2024

Evolution of Eligibility Criteria in Inflammatory Bowel Disease Clinical Trials: A Clinical Trial Databank Analysis.

Evolution of Eligibility Criteria in Inflammatory Bowel Disease Clinical Trials: A Clinical Trial Databank Analysis.

Journal: United European gastroenterology journal

Published: July 26, 2024

Opportunities and Challenges in Cross-Country Collaboration: Insights from the Beneluxa Initiative.

Opportunities and Challenges in Cross-Country Collaboration: Insights from the Beneluxa Initiative.

Journal: Journal of market access & health policy

Published: April 08, 2024

Showing 1-12 of 35

Last Updated: 09/26/2026